Patient-Derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell Carcinomas

类有机物 结直肠癌 医学 印戒细胞 癌症研究 病理 肿瘤科 内科学 生物 腺癌 癌症 神经科学
作者
Nazia Chaudhary,Alessandro La Ferlita,Bhagya Shree Choudhary,Eeshrita Jog,Mufaddal Khuzema Kazi,Showket Yahya,Afiya Dalwai,Vikas S Ostwal,Satishkumar Vishram Singh,Siddhi Redkar,Nileema Khapare,Vaishali Kailaje,B Akshaya,Poonam B. Gera,Munita Meenu Bal,Nandini Verma,Rahul A. Thorat,Avanish P Saklani,Lalit Sehgal,Sorab Nariman Dalal
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:31 (7): 1359-1373 被引量:13
标识
DOI:10.1158/1078-0432.ccr-24-2329
摘要

PURPOSE: Identifying therapeutic targets for signet ring cell carcinoma (SRCC) of the colon and rectum is a clinical challenge because of the lack of patient-derived organoids (PDO) or patient-derived xenografts (PDX). To address this unmet need, we present a robust method for establishing PDO and PDX models. We demonstrate that these models identify novel therapeutic strategies targeting therapy resistance and peritoneal metastasis. EXPERIMENTAL DESIGN: We derived nine PDO and PDX models from patients with colorectal SRCC. Detailed histopathologic characterization confirmed the fidelity of these models to the original tumors. Drug sensitivity assays were conducted in vitro and in vivo to assess the therapeutic efficacy and impact on peritoneal metastasis. An RNA sequencing analysis was performed to identify critical pathways contributing to therapy resistance and metastatic progression. RESULTS: We successfully developed and characterized PDO and PDX models from nine patients with SRCC. The SRCC PDO and PDX models exhibited histopathologic features consistent with those of the original tumors, including high mucin content and eccentric nuclei. They demonstrated increased sensitivity to FOLFIRI combined with paclitaxel or vincristine, reducing peritoneal metastasis. RNA sequencing analysis revealed the upregulation of autophagy genes in SRCC. Treatment with chloroquine alone resulted in decreased tumor growth and peritoneal metastasis. CONCLUSIONS: Our study establishes PDO and PDX models as robust platforms for studying SRCC and identifying potential therapeutic strategies. Combining FOLFIRI with paclitaxel/vincristine or chloroquine alone inhibits tumor growth and prevents peritoneal metastasis, showing promise for clinical translation. These findings suggest that combining FOLFIRI with intraperitoneal paclitaxel warrants further investigation in phase I clinical trials for patients with SRCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhangyq完成签到,获得积分10
刚刚
1秒前
1秒前
打打的应助被Leo采纳,获得10
2秒前
2秒前
Ava的应助被yangyutong采纳,获得10
2秒前
2秒前
lmx发布了新的文献求助10
3秒前
小迷鹿完成签到,获得积分10
3秒前
ZZZ完成签到,获得积分10
3秒前
11发布了新的文献求助10
3秒前
小蘑菇的应助被甜甜的青梦采纳,获得10
4秒前
JamesPei的应助被尹兴亮采纳,获得10
4秒前
爆米花的应助被端庄的夏寒采纳,获得10
4秒前
4秒前
被风吹过的路的应助被茉莉媛采纳,获得10
4秒前
5秒前
xiao发布了新的文献求助10
5秒前
5秒前
情怀的应助被zhangyq采纳,获得10
6秒前
又又发布了新的文献求助10
6秒前
7秒前
Hello的应助被leilei采纳,获得10
7秒前
风趣健柏完成签到,获得积分10
8秒前
羊一个完成签到,获得积分10
9秒前
10秒前
健康的吐司完成签到,获得积分10
10秒前
jlio完成签到,获得积分10
10秒前
充电宝的应助被Drcai采纳,获得10
10秒前
11秒前
Stern12138完成签到 ,获得积分10
11秒前
李健的应助被11采纳,获得10
12秒前
HJ发布了新的文献求助10
12秒前
moriaty发布了新的文献求助20
12秒前
12秒前
12秒前
12秒前
水煮电吹风的应助被12345采纳,获得10
13秒前
嘻嘻哈哈的应助被balko采纳,获得10
13秒前
Hello的应助被四方采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187652
求助须知:如何正确求助?哪些是违规求助? 9575758
关于积分的说明 21842805
捐赠科研通 7785538
什么是DOI,文献DOI怎么找? 3435073
关于科研通互助平台的介绍 2559480
邀请新用户注册赠送积分活动 2481963